Acuta Capital Partners’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-174,650
| Closed | -$36.5M | – | 44 |
|
|
2020
Q2 | $36.5M | Buy |
174,650
+4,200
| +2% | +$877K | 10.54% | 1 |
|
|
2020
Q1 | $16.7M | Buy |
170,450
+38,200
| +29% | +$3.73M | 8.07% | 3 |
|
|
2019
Q4 | $15.2M | Buy |
+132,250
| New | +$15.2M | 3.77% | 7 |
|
|
2019
Q3 | – | Sell |
-119,000
| Closed | -$14.1M | – | 31 |
|
|
2019
Q2 | $14.1M | Buy |
119,000
+27,100
| +29% | +$3.22M | 5.03% | 3 |
|
|
2019
Q1 | $4.82M | Buy |
+91,900
| New | +$4.82M | 2.29% | 18 |
|